High Court Immunity Ruling Likely To Further Delay Trump Trial
Portfolio Pulse from Benzinga Newsdesk
The High Court's ruling on immunity is expected to further delay the trial of former President Donald Trump. This development could have implications for the stock market, particularly for ETFs like SPY that track the S&P 500 index.
July 01, 2024 | 2:31 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
The High Court's ruling on immunity, which is expected to delay the trial of former President Donald Trump, could lead to increased market uncertainty. SPY, an ETF that tracks the S&P 500, may experience short-term volatility as a result.
The delay in Trump's trial due to the High Court's ruling on immunity could increase market uncertainty. SPY, which tracks the S&P 500, may see short-term volatility as investors react to the news.
CONFIDENCE 80
IMPORTANCE 60
RELEVANCE 50